Related Experiment Video
Updated: May 5, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
18.1K
Pathological staging of melanoma
1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 22, 2013
Summary
Pathological staging, or microstaging, of melanoma uses histopathology to assess cancer extent. Key prognostic factors like Breslow thickness and ulceration aid survival estimation in staging systems.
Area of Science:
- Oncology
- Pathology
- Dermatology
Background:
- Cancer staging describes disease extent.
- Pathological staging (microstaging) uses histopathology.
- Melanoma microstaging analyzes prognostic attributes for survival estimation.
Purpose of the Study:
- To detail microstaging for melanoma.
- To discuss prognostic variables and their significance.
- To present prognostic models, including the AJCC staging system.
Main Methods:
- Histopathological examination of primary tumors and metastases.
- Analysis of prognostic variables such as Breslow thickness, ulceration, and mitogenicity.
- Utilizing prognostic models like the AJCC/UICC staging system.
Main Results:
- Breslow thickness, ulceration, and mitogenicity are key prognostic factors in primary melanoma.
- Other relevant factors include tumor-infiltrating lymphocytes, invasion, and growth phase.
- Prognostic models aid in estimating survival rates based on these variables.
Conclusions:
- Microstaging is crucial for determining melanoma prognosis.
- Understanding prognostic variables enhances pathological interpretation.
- The AJCC staging system provides a framework for melanoma staging and survival prediction.
